BridgeBio Pharma, Inc. (BBIO)
Analyst consensus, price target and coverage. 21 analysts, updated daily.
Analyst votes
How the ratings break down
22 ratings on record
- Strong Buy6
- Buy14
- Hold2
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 80.00
Mean 107.62
High 157.00
share price 81.21 mean target 107.62. Analysts are spread 96% apart.
Most recent action
Last rating change
| Firm | Truist Securities |
|---|---|
| Date | 2026-08-12 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 15.88B USD |
|---|---|
| Cap class | Large |
| Average volume | 3,310,848 |
| Dollar volume per day | 268.9M |
| Liquidity | High |
| Internal score | 81.9 / 100 |
Recommendation
How it moved, scan by scan
3 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-14 07:41 | = | Strong Buy | 1.82 | 6 | 14 | 2 | 0 | 0 |
| 2026-08-13 | = | Strong Buy | 1.82 | 6 | 14 | 2 | 0 | 0 |
| 2026-08-11 | · | Strong Buy | 1.82 | 6 | 14 | 2 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
3 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-14 | 81.21 | 107.62 | +32.5% | Strong Buy |
| 2026-08-13 | 83.84 | 107.62 | +28.4% | Strong Buy |
| 2026-08-11 | 83.96 | 107.62 | +28.2% | Strong Buy |
Similar coverage
Comparable large-cap names
Closest upside among companies of the same size.